Discount Agreement for Omalizumab (ATC L04AG08)
Enter into a non-exclusive discount agreement for Omalizumab (ATC L04AG08) with DAK-Gesundheit. This agreement is valid from 08/01/2026 to 07/31/2028, allowing all interested pharmaceutical companies to participate.
CONTRACTING AUTHORITY
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
718 days remaining(LOT-0001)
Published